Monocedocard en es it fr

Monocedocard Brand names, Monocedocard Analogs

Monocedocard Brand Names Mixture

  • No information avaliable

Monocedocard Chemical_Formula


Monocedocard RX_link

Monocedocard fda sheet

Monocedocard msds (material safety sheet)

Monocedocard MSDS

Monocedocard Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Monocedocard Molecular Weight

191.139 g/mol

Monocedocard Melting Point


Monocedocard H2O Solubility

1.07E+005 mg/L

Monocedocard State


Monocedocard LogP


Monocedocard Dosage Forms

Tablet (immediate release); Tablet (extended release)

Monocedocard Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Monocedocard Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Monocedocard Absorption


Monocedocard side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)

Monocedocard Patient Information

Monocedocard Organisms Affected

Humans and other mammals